NCT05505305

Brief Summary

This study will investigate the effects of seven weeks of time-restricted eating combined with high-intensity interval training compared with a control group on body composition in adults with overweight/obesity. Participants in the intervention group will complete the intervention remotely and will receive weekly follow-up through online platforms (telephone, video call). Before and after the intervention, the investigators will measure the participants' body composition, physical fitness, fasting blood glucose and insulin, blood lipids, and blood pressure. Physical activity, diet, sleep quality, appetite, and adherence to the intervention will also be measured. Secondary sub-analyses of sex differences in the responses to the intervention will be performed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 17, 2022

Completed
15 days until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 13, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 13, 2024

Completed
Last Updated

June 21, 2024

Status Verified

June 1, 2024

Enrollment Period

1.7 years

First QC Date

August 16, 2022

Last Update Submit

June 19, 2024

Conditions

Keywords

time-restricted eatinghigh-intensity interval trainingexercisedietbody composition

Outcome Measures

Primary Outcomes (1)

  • Total fat mass

    Change in total fat mass measured with bioelectrical impedance analysis

    From baseline to after 7 weeks of intervention

Secondary Outcomes (21)

  • Blood glucose

    From baseline to after 7 weeks of intervention

  • Insulin

    From baseline to after 7 weeks of intervention

  • Average glucose levels

    From baseline to after 7 weeks of intervention

  • Blood Cholesterol

    From baseline to after 7 weeks of intervention

  • HDL-cholesterol in blood

    From baseline to after 7 weeks of intervention

  • +16 more secondary outcomes

Other Outcomes (6)

  • Adherence to high-intensity interval training

    Seven weeks

  • Compliance to high-intensity interval training

    Seven weeks

  • Adherence to time-restricted eating

    Seven weeks

  • +3 more other outcomes

Study Arms (2)

Time-restricted eating and high-intensity interval training

EXPERIMENTAL

Seven weeks of time-restricted eating and high-intensity interval training with digital follow-up.

Behavioral: Time-restricted eating and high-intensity interval training

Control

NO INTERVENTION

No intervention nor digital follow-up for seven weeks.

Interventions

Maximal daily eating window of 10 hours and high-intensity interval training (three weekly, unsupervised, aerobic exercise sessions performed at \> 90 % heart rate maximum). Each exercise session will last for 33-38 minutes. Participants will receive digital follow-up once weekly. The intervention period will be seven weeks,

Time-restricted eating and high-intensity interval training

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Body mass index ≥ 27 kg/m²
  • Able to walk or ride a bike \> 60 min

You may not qualify if:

  • On-going pregnancy
  • Lactation within 24 weeks of study commencement
  • High-intensity exercise ≥ 1/week
  • Habitual eating window ≤12 hours/day
  • Taking hypertension, glucose-, or lipid-lowering drugs
  • Body mass variation ≥ 4 kg three months prior to study commencement
  • Known diabetes mellitus (type 1 or 2) or cardiovascular disease
  • Working night shifts

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of circulation and medical imaging, NTNU

Trondheim, 7491, Norway

Location

MeSH Terms

Conditions

OverweightObesityIntermittent FastingMotor Activity

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsFastingFeeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Øivind Rognmo, PhD

    Norwegian University of Science and Technology, Trondheim, Norway

    STUDY DIRECTOR
  • Trine Moholdt, PhD

    Norwegian University of Science and Technology, Trondheim, Norway

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2022

First Posted

August 17, 2022

Study Start

September 1, 2022

Primary Completion

May 13, 2024

Study Completion

May 13, 2024

Last Updated

June 21, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations